Ricciardi, L.; Chatterjee, S.; Palermo, G.; Szerb, E.I.; Sanna, A.; Palermo, F.; Pieroni, N.; Fratini, M.; Bartolino, R.; Cedola, A.;
et al. Hybrid Nanoparticles as Theranostics Platforms for Glioblastoma Treatment: Phototherapeutic and X-ray Phase Contrast Tomography Investigations. J. Nanotheranostics 2022, 3, 1-17.
https://doi.org/10.3390/jnt3010001
AMA Style
Ricciardi L, Chatterjee S, Palermo G, Szerb EI, Sanna A, Palermo F, Pieroni N, Fratini M, Bartolino R, Cedola A,
et al. Hybrid Nanoparticles as Theranostics Platforms for Glioblastoma Treatment: Phototherapeutic and X-ray Phase Contrast Tomography Investigations. Journal of Nanotheranostics. 2022; 3(1):1-17.
https://doi.org/10.3390/jnt3010001
Chicago/Turabian Style
Ricciardi, Loredana, Sharmistha Chatterjee, Giovanna Palermo, Elisabeta I. Szerb, Alessia Sanna, Francesca Palermo, Nicola Pieroni, Michela Fratini, Roberto Bartolino, Alessia Cedola,
and et al. 2022. "Hybrid Nanoparticles as Theranostics Platforms for Glioblastoma Treatment: Phototherapeutic and X-ray Phase Contrast Tomography Investigations" Journal of Nanotheranostics 3, no. 1: 1-17.
https://doi.org/10.3390/jnt3010001
APA Style
Ricciardi, L., Chatterjee, S., Palermo, G., Szerb, E. I., Sanna, A., Palermo, F., Pieroni, N., Fratini, M., Bartolino, R., Cedola, A., La Deda, M., & Strangi, G.
(2022). Hybrid Nanoparticles as Theranostics Platforms for Glioblastoma Treatment: Phototherapeutic and X-ray Phase Contrast Tomography Investigations. Journal of Nanotheranostics, 3(1), 1-17.
https://doi.org/10.3390/jnt3010001
